1. FM-WEBSITE

Search Page

[current-page:query:search_api_aggregation_1]

Filter and Sort

Content type

801 - 810 of 2170
Paper

Cell-type-specific transcriptional regulation of PIGM underpins the divergent hematologic phenotype in inherited GPl deficiency

António Almeida (with Joana R. Costa). 2014. Blood
Download and More Details
Paper

Design and rationale of the QUAZAR lower-risk MDS (AZA-MDS-003) trial: a randomized phase 3 study of CC-486 (oral azacitidine) plus best supportive care vs placebo plus best supportive care in patients with IPSS lower-risk myelodysplastic syndromes a...

António Almeida (with Garcia-Manero, G.). 2016. BMC Hematology
Download and More Details
Paper

Recent advances in the treatment of lower-risk non-del(5q) myelodysplastic syndromes (MDS)

António Almeida (with António Almeida). 2017. Leukemia Research
Download and More Details
Paper

Optimizing treatments in rare diseases: Will our evidence come from registry data?

António Almeida (with Almeida, A.M.). 2014. Leukemia Research
Download and More Details
Paper

Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+)

António Almeida (with Falantes, J.). 2017. Leukemia and Lymphoma
Download and More Details